Intra-Cellular Therapies (ITCI) Insider Trading & Ownership

$80.39

-0.45 (-0.56%)

(As of 07/26/2024 ET)

Current Insider Ownership Percentage: 3.40%
Number Of Insiders Buying (Last 12 Months): 0
Number Of Insiders Selling (Last 12 Months): 9
Amount Of Insider Selling (Last 12 Months): $40.43 M

Get ITCI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Intra-Cellular Therapies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ITCI Insider Buying and Selling by Quarter

Ad DTI

Heard about the 72-Hour Profit Surge? Read this…

One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge... A short period of time where we can bet on a stock that is ALREADY “winning.” Let me give you a perfect example of how the Surge worked with Ross Stores. Back on November 16th, a little move was made that sent their stock soaring… The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge…

Click here now to get all the details.

Intra-Cellular Therapies Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
6/24/2024	Rory B Riggs	Director	Sell	4,462	$75.57	$337,193.34
6/21/2024	Josh Gottheimer	U.S. Congress Member (D-NJ)	Sell		$76.58	$1,001 - $15,000
6/18/2024	Nostrand Robert L Van	Director	Sell	20,000	$75.91	$1,518,200.00
3/11/2024	Lawrence J. Hineline	CFO	Sell	10,121	$65.96	$667,581.16
3/11/2024	Michael Halstead	EVP	Sell	7,345	$65.97	$484,549.65
3/11/2024	Sharon Mates	CEO	Sell	20,565	$65.21	$1,341,043.65
3/7/2024	Lawrence J. Hineline	CFO	Sell	13,132	$66.60	$874,591.20
Get Insider Trades Delivered To Your Inbox Enter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings.
3/7/2024	Sharon Mates	CEO	Sell	40,712	$66.50	$2,707,348.00
3/7/2024	Suresh K Durgam	EVP	Sell	6,450	$66.56	$429,312.00
2/26/2024	Joel S Marcus	Director	Sell	26,328	$68.68	$1,808,207.04
2/26/2024	Lawrence J. Hineline	CFO	Sell	13,337	$69.43	$925,987.91
2/26/2024	Michael Halstead	EVP	Sell	7,907	$69.53	$549,773.71
2/26/2024	Sharon Mates	CEO	Sell	22,590	$69.79	$1,576,556.10
1/18/2024	Sharon Mates	CEO	Sell	67,917	$65.19	$4,427,509.23
1/16/2024	Sharon Mates	CEO	Sell	75,361	$67.25	$5,068,027.25
1/11/2024	Michael Halstead	EVP	Sell	50,000	$66.83	$3,341,500.00
1/2/2024	Suresh K. Durgam	EVP	Sell	62,282	$70.60	$4,397,109.20
12/13/2023	Suresh K. Durgam	EVP	Sell	21,262	$65.00	$1,382,030.00
11/6/2023	Mark Neumann	EVP	Sell	42,393	$55.63	$2,358,322.59
9/18/2023	Sharon Mates	CEO	Sell	55,587	$53.76	$2,988,357.12
8/7/2023	Mark Neumann	EVP	Sell	55,300	$58.79	$3,251,087.00

(Data available from 1/1/2013 forward)

ITCI Insider Trading Activity - Frequently Asked Questions

Who is on Intra-Cellular Therapies's Insider Roster?: The list of insiders at Intra-Cellular Therapies includes Joel S Marcus, Lawrence J Hineline, Mark Neumann, Michael Halstead, Nostrand Robert L Van, Rory B Riggs, Sharon Mates, Suresh K Durgam. Learn more on insiders at ITCI.
What percentage of Intra-Cellular Therapies stock is owned by insiders?: 3.40% of Intra-Cellular Therapies stock is owned by insiders. Learn more on ITCI's insider holdings.
Which Intra-Cellular Therapies insiders have been selling company stock?: The following insiders have sold ITCI shares in the last 24 months: Joel S Marcus ($2,062,307.04), Lawrence J. Hineline ($15,131,817.36), Mark Neumann ($7,563,434.74), Michael Halstead ($7,062,323.36), Nostrand Robert L Van ($3,862,100.00), Rory B Riggs ($337,193.34), Sharon Mates ($25,022,530.74), and Suresh K Durgam ($1,643,805.96).

How much insider selling is happening at Intra-Cellular Therapies?: Insiders have sold a total of 1,168,821 Intra-Cellular Therapies shares in the last 24 months for a total of $68,464,651.74 sold.
Which members of congress are trading Intra-Cellular Therapies?: Josh Gottheimer (D-NJ) has sold shares of Intra-Cellular Therapies in the last year totaling $8,000.